Inhibitors of HIV reverse transcriptase
US5308854A · kind A · utility
50Cited by
8References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 4, 1992 |
| Grant date | May 3, 1994 |
| Priority date | — |
| Expiry date | Nov 4, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel aminopyridones inhibit HIV reverse transcriptase, and are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, anti-infectives, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.